CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241814030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Javed Akhtar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Futian Biomedical Innovation R&D Center, The Chinese University of Hong Kong, Shenzhen 518172, China. Hauptthemen laut MEDLINE: Alcohol Oxidoreductases, Esophageal Squamous Cell Carcinoma, Drug Resistance, Neoplasm, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation, National Key R&D Program of China.
Abstract (Originalsprache)
Innovative therapeutic strategies for esophageal squamous cell carcinoma (ESCC) are urgently required due to the limited effectiveness of standard chemotherapies. C-Terminal Binding Protein 1 (CtBP1) has been implicated in various cancers, including ESCC. However, the precise expression patterns and functional roles of CtBP1 in ESCC remain inadequately characterized. In this study, we aimed to investigate CtBP1 expression and its role in the resistance of ESCC to paclitaxel, an effective chemotherapeutic agent. Western blotting and immunofluorescence were applied to assess CtBP1 expression in the TE-1 and KYSE-50 cell lines. We observed the marked expression of CtBP1, which was associated with enhanced proliferation, invasion, and metastasis in these cell lines. Further, we successfully generated paclitaxel resistant ESCC cell lines and conducted cell viability assays. We employed the CRISPR/Cas9 genome editing system to disable the CtBP1 gene in ESCC cell lines. Through the analysis of the drug dose–response curve, we assessed the sensitivity of these cell lines in different treatment groups. Remarkably, CtBP1-disabled cell lines displayed not only improved sensitivity but also a remarkable inhibition of proliferation, invasion, and metastasis. This demonstrates that CtBP1 may promote ESCC cell malignancy and confer paclitaxel resistance. In summary, our study opens a promising avenue for targeted therapies, revealing the potential of CtBP1 inhibition to enhance the effectiveness of paclitaxel treatment for the personalized management of ESCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Futian Biomedical Innovation R&D Center, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Biomedical Science and Engineering, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Center for Endocrinology and Metabolic Diseases, Second Affiliated Hospital, The Chinese University of Hong Kong, Shenzhen 518172, China.
- Department of Computer Science & IT, Institute of Southern Punjab, Multan 60800, Pakistan.
ORCID-Profile: Guanyu Wang
Förderung
- National Natural Science Foundation of China
- Shenzhen-Hong Kong Cooperation Zone for Technology and Innovation
- National Key R&D Program of China
- Guangdong Provincial Research Funds
Zitieren
APA
Akhtar, J., Imran, M., & Wang, G. (2023). CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814030
Vancouver
Akhtar J, Imran M, Wang G. CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814030
BibTeX
@article{Akhtar2023,
author = {Akhtar, Javed and Imran, Muhammad and Wang, Guanyu},
title = {CRISPR/Cas9-Mediated CtBP1 Gene Editing Enhances Chemosensitivity and Inhibits Metastatic Potential in Esophageal Squamous Cell Carcinoma Cells},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241814030}
}
EUVIMED